These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 35181789)

  • 1. Standardized Definitions of In Utero Human Immunodeficiency Virus and Antiretroviral Drug Exposure Among Children.
    Slogrove AL; Burmen B; Davies MA; Edmonds A; Abrams EJ; Chadwick EG; Goetghebuer T; Mofenson LM; Paul ME; Thorne C; Williams PL; Vicari M; Powis KM
    Clin Infect Dis; 2022 Aug; 75(2):347-355. PubMed ID: 35181789
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Safety of agents used to prevent mother-to-child transmission of HIV: is there any cause for concern?
    Thorne C; Newell ML
    Drug Saf; 2007; 30(3):203-13. PubMed ID: 17343429
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antiretroviral therapy (ART) for treating HIV infection in ART-eligible pregnant women.
    Sturt AS; Dokubo EK; Sint TT
    Cochrane Database Syst Rev; 2010 Mar; (3):CD008440. PubMed ID: 20238370
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pregnancy and infant outcomes among HIV-infected women taking long-term ART with and without tenofovir in the DART trial.
    Gibb DM; Kizito H; Russell EC; Chidziva E; Zalwango E; Nalumenya R; Spyer M; Tumukunde D; Nathoo K; Munderi P; Kyomugisha H; Hakim J; Grosskurth H; Gilks CF; Walker AS; Musoke P;
    PLoS Med; 2012; 9(5):e1001217. PubMed ID: 22615543
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Point-of-care capillary blood lactate measurements in human immunodeficiency virus-uninfected children with in utero exposure to human immunodeficiency virus and antiretroviral medications.
    Crain MJ; Williams PL; Griner R; Tassiopoulos K; Read JS; Mofenson LM; Rich KC;
    Pediatr Infect Dis J; 2011 Dec; 30(12):1069-74. PubMed ID: 22051859
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antiretroviral use during pregnancy for treatment or prophylaxis.
    Sturt AS; Read JS
    Expert Opin Pharmacother; 2011 Aug; 12(12):1875-85. PubMed ID: 21534886
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Congenital anomalies and in utero antiretroviral exposure in human immunodeficiency virus-exposed uninfected infants.
    Williams PL; Crain MJ; Yildirim C; Hazra R; Van Dyke RB; Rich K; Read JS; Stuard E; Rathore M; Mendez HA; Watts DH;
    JAMA Pediatr; 2015 Jan; 169(1):48-55. PubMed ID: 25383770
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Safety of antiretroviral prophylaxis of perinatal transmission for HIV-infected pregnant women and their infants.
    Mofenson LM; Munderi P
    J Acquir Immune Defic Syndr; 2002 Jun; 30(2):200-15. PubMed ID: 12045684
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of maternal antiretroviral use with microcephaly in children who are HIV-exposed but uninfected (SMARTT): a prospective cohort study.
    Williams PL; Yildirim C; Chadwick EG; Van Dyke RB; Smith R; Correia KF; DiPerna A; Seage GR; Hazra R; Crowell CS;
    Lancet HIV; 2020 Jan; 7(1):e49-e58. PubMed ID: 31740351
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Initiation of antiretroviral therapy or antiretroviral prophylaxis in pregnant women living with HIV registered in five townships of Mandalay, Myanmar: A cross sectional study.
    Kyaw KWY; Mon AA; Phyo KH; Kyaw NTT; Kumar AMV; Lwin TT; Aung ZZ; Aung TK; Oo MM; Htun T; Ya SST; Satyanarayana S; Oo HN
    BMC Pregnancy Childbirth; 2019 Dec; 19(1):475. PubMed ID: 31805892
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neurodevelopmental effects of ante-partum and post-partum antiretroviral exposure in HIV-exposed and uninfected children versus HIV-unexposed and uninfected children in Uganda and Malawi: a prospective cohort study.
    Boivin MJ; Maliwichi-Senganimalunje L; Ogwang LW; Kawalazira R; Sikorskii A; Familiar-Lopez I; Kuteesa A; Nyakato M; Mutebe A; Namukooli JL; Mallewa M; Ruiseñor-Escudero H; Aizire J; Taha TE; Fowler MG
    Lancet HIV; 2019 Aug; 6(8):e518-e530. PubMed ID: 31122797
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antenatal and neonatal antiretroviral therapy in HIV-infected women and their infants: a review of safety issues.
    Thorne C; Newell ML
    Med Wieku Rozwoj; 2003; 7(4 Pt 1):425-36. PubMed ID: 15010553
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Pregnancy: a model of prevention of HIV transmission].
    Mandelbrot L
    Bull Acad Natl Med; 2014; 198(4-5):813-24. PubMed ID: 26753411
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pregnancy incidence and outcomes among women receiving preexposure prophylaxis for HIV prevention: a randomized clinical trial.
    Mugo NR; Hong T; Celum C; Donnell D; Bukusi EA; John-Stewart G; Wangisi J; Were E; Heffron R; Matthews LT; Morrison S; Ngure K; Baeten JM;
    JAMA; 2014 Jul 23-30; 312(4):362-71. PubMed ID: 25038355
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lack of long-term effects of in utero exposure to zidovudine among uninfected children born to HIV-infected women. Pediatric AIDS Clinical Trials Group Protocol 219/076 Teams.
    Culnane M; Fowler M; Lee SS; McSherry G; Brady M; O'Donnell K; Mofenson L; Gortmaker SL; Shapiro DE; Scott G; Jimenez E; Moore EC; Diaz C; Flynn PM; Cunningham B; Oleske J
    JAMA; 1999 Jan; 281(2):151-7. PubMed ID: 9917118
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tolerance of the newborn to antiretroviral drug exposure in utero.
    Sibiude J; Warszawski J; Blanche S
    Expert Opin Drug Saf; 2015 May; 14(5):643-54. PubMed ID: 25727366
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Emerging evidence from a systematic review of safety of pre-exposure prophylaxis for pregnant and postpartum women: where are we now and where are we heading?
    Joseph Davey DL; Pintye J; Baeten JM; Aldrovandi G; Baggaley R; Bekker LG; Celum C; Chi BH; Coates TJ; Haberer JE; Heffron R; Kinuthia J; Matthews LT; McIntyre J; Moodley D; Mofenson LM; Mugo N; Myer L; Mujugira A; Shoptaw S; Stranix-Chibanda L; John-Stewart G;
    J Int AIDS Soc; 2020 Jan; 23(1):e25426. PubMed ID: 31912985
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Medication adherence in pregnant women with human immunodeficiency virus receiving antiretroviral therapy in sub-Saharan Africa: a systematic review.
    Omonaiye O; Kusljic S; Nicholson P; Manias E
    BMC Public Health; 2018 Jun; 18(1):805. PubMed ID: 29945601
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antiretrovirals for reducing the risk of mother-to-child transmission of HIV infection.
    Siegfried N; van der Merwe L; Brocklehurst P; Sint TT
    Cochrane Database Syst Rev; 2011 Jul; (7):CD003510. PubMed ID: 21735394
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evolving treatment implementation among HIV-infected pregnant women and their partners: results from a national surveillance study in Italy, 2001-2015.
    Floridia M; Frisina V; Ravizza M; Marconi AM; Pinnetti C; Cetin I; Sansone M; Molinari A; Cervi F; Meloni A; Luzi K; Masuelli G; Tamburrini E;
    J Glob Health; 2017 Jun; 7(1):010407. PubMed ID: 28567279
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.